Pharvaris (PHVS) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

PHVS Pharvaris

Watchlist

20.675
+0.175+0.85%

Trading Nov 21 14:45 ET

1.12BMarket Cap-7542P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Pharvaris's Strategic Progress in HAE Pipeline Drives Buy Rating and $30 Price Target
TipRanksNov 19 01:55 ET · Ratings
Oppenheimer Maintains Pharvaris(PHVS.US) With Buy Rating, Maintains Target Price $42
Moomoo NewsNov 14 08:31 ET · Ratings
Oppenheimer Remains a Buy on Pharvaris (PHVS)
TipRanksNov 14 07:58 ET · Ratings
Pharvaris Reports Q3 EPS (EUR 0.77) Vs (EUR 0.58) Last Year
TipRanksNov 13 16:30 ET
Pharvaris | 6-K: Report of foreign private issuer (related to financial reporting)
SECNov 13 16:18 ET · Announcements
Press Release: Pharvaris Reports Third Quarter 2024 Financial Results and Highlights Recent Business Updates
Dow JonesNov 13 16:10 ET

Comments

70617300

Aug 15 08:18

Oppenheimer analyst Jeff Jones maintains $Pharvaris (PHVS.US)$ with a buy rating, and maintains the target price at $38.
According to TipRanks data, the analyst has a success rate of 36.7% and a total average return of 6.4% over the past year.

Alvinnnnnnngenius

Dec 6, 2023 05:50

$Pharvaris (PHVS.US)$ Pharvaris Announces Positive Top-line Phase 2 Data from the CHAPTER-1 Study of Deucrictibant for the Prophylactic Treatment of HAE Attacks

BioPharm Insight US

Dec 12, 2022 10:20

Columns Weekly FDA Drug Pipeline Calendar (Dec 12 - Dec 17)

Hello mooers, welcome to another week of the FDA calendar. Here are what happened last week and what's coming up this week.
$Amgen (AMGN.US)$ Inc. is in advanced talks to buy drug company $Horizon Therapeutics (HZNP.US)$, according to people familiar with the matter, in a takeover likely to be valued at well over $20 billion and mark the largest healthcare merger of the year.
$ROCHESTER RESOURCES LTD (RCTFF.US)$Holding AG presented new data from a ...